Amyloidogenicity and Aggregate Cytotoxicity of Human Glucagon-Like Peptide-1 (hGLP-1)

被引：19

作者：

Poon, S. ^{[1
]}

Birkett, N. R. ^{[1
]}

Fowler, S. B. ^{[2
]}

Luisi, B. F. ^{[3
]}

Dobson, C. M. ^{[1
]}

Zurdo, J. ^{[2
]}

机构：

[1] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England

[2] Zyentia Ltd, Cambridge CB22 3AT, England

[3] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England

来源：

PROTEIN AND PEPTIDE LETTERS | 2009年 / 16卷 / 12期

关键词：

hGLP-1; protein aggregation; biopharmaceuticals; diabetes; amyloid fibrils; Alzheimer's disease; AMYLOID FIBRIL FORMATION; X-RAY-DIFFRACTION; NEURONAL DEGENERATION; THERAPEUTIC PEPTIDE; DIABETES-MELLITUS; GLOBULAR PROTEIN; SELF-ASSOCIATION; HUMAN CALCITONIN; HUMAN-DISEASE; SH3; DOMAIN;

D O I：

10.2174/092986609789839232

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The potential of human glucagon-like peptide-1 (hGLP-1) as a therapeutic agent is limited by its high aggregation propensity. We show that hGLP-1 forms amyloid-like structures that are preceded by cytotoxic aggregates, suggesting that aggregation of biopharmaceuticals could present a cytotoxic risk to patients besides the reported increased risk in immunogenicity.

引用

页码：1548 / 1556

页数：9

共 50 条

[41] Immunohistochemical Glucagon-like Peptide-1 Receptor Expression in Human Insulinomas
Vesterinen, Tiina
Peltola, Elina
Leijon, Helena
Hannula, Paeivi
Huhtala, Heini
Makinen, Markus J.
Nieminen, Lasse
Pirinen, Elina
Ronty, Mikko
Soderstrom, Mirva
Jaatinen, Pia
Arola, Johanna
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (20)
[42] Comment on: "Glucagon-like peptide-1 receptor expression in the human eye"
Simo, Rafael
Hernandez, Cristina
DIABETES OBESITY & METABOLISM, 2019, 21 (02): : 446 - 447
[43] Glucagon-like peptide-1 receptor is expressed in human and rodent testis
Caltabiano, Rosario
Condorelli, Daniele
Panza, Salvatore
Boitani, Carla
Musso, Nicolo
Jezek, Davor
Memeo, Lorenzo
Colarossi, Lorenzo
Rago, Vittoria
Mularoni, Valentina
Spadola, Saveria
Castiglione, Roberto
Santoro, Marta
Aquila, Saveria
D'Agata, Rosario
ANDROLOGY, 2020, 8 (06) : 1935 - 1945
[44] CLONING AND FUNCTIONAL EXPRESSION OF A HUMAN GLUCAGON-LIKE PEPTIDE-1 RECEPTOR
GRAZIANO, MP
HEY, PJ
BORKOWSKI, D
CHICCHI, GG
STRADER, CD
JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 135 - 135
[45] Expression of the glucagon-like peptide-1 receptor and glucokinase in human brain
Roncero, I
Alvarez, E
Chowen, J
Rabano, A
Garcia-Cuartero, B
Sanz, C
Blázquez, E
DIABETOLOGIA, 2000, 43 : A30 - A30
[46] Inhibition of Human Gastric Lipase Secretion by Glucagon-like Peptide-1
Morten Wojdemann
Andre Wettergren
Berit Sternby
Jens J. Holst
Steen Larsen
Jens F. Rehfeld
Ole Olsen
Digestive Diseases and Sciences, 1998, 43 : 799 - 805
[47] Stimulation of glucagon-like peptide-1 secretion by water loading in human
A. S. Marina
A. V. Kutina
E. I. Shakhmatova
E. V. Balbotkina
Yu. V. Natochin
Doklady Biological Sciences, 2014, 459 (1) : 323 - 325
[48] Inhibition of human gastric lipase secretion by glucagon-like peptide-1
Wojdemann, M
Wettergren, A
Sternby, B
Holst, JJ
Larsen, S
Rehfeld, JF
Olsen, O
DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (04) : 799 - 805
[49] GLUCAGON-LIKE PEPTIDE-1 IS A PHYSIOLOGICAL INCRETIN IN RAT
WANG, ZL
WANG, RM
OWJI, AA
SMITH, DM
GHATEI, MA
BLOOM, SR
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (01): : 417 - 421
[50] The effect of glucagon-like peptide-1 and glucagon-like peptide-2 on microcirculation: A systematic review
Nerup, Nikolaj
Ambrus, Rikard
Lindhe, Joanna
Achiam, Michael P.
Jeppesen, Palle B.
Svendsen, Lars B.
MICROCIRCULATION, 2019, 26 (03)

← 1 2 3 4 5 →